**Core Concept**
Early-stage laryngeal cancer, specifically T1 carcinoma of the larynx without any lymph node metastasis (NOMO), requires a treatment approach that preserves laryngeal function while effectively eliminating the tumor. This involves a delicate balance between oncological efficacy and minimizing treatment-related morbidity.

**Why the Correct Answer is Right**
The treatment of choice for T1 carcinoma of the larynx NOMO involves **surgical excision** using a laser or a conservative surgical approach, such as **endoscopic laser surgery** or **open partial laryngectomy**. These methods aim to remove the tumor while maintaining laryngeal function. **Radiotherapy** can also be an option, especially in cases where surgical approaches are not feasible or preferred.

**Why Each Wrong Option is Incorrect**
**Option A:** **Neoadjuvant chemotherapy** is not typically used as a standalone treatment for T1 laryngeal cancer, as the primary goal is to preserve laryngeal function.
**Option B:** **Total laryngectomy** is a more aggressive approach usually reserved for larger or more advanced tumors.
**Option C:** **Radiation therapy alone** might be considered in certain cases, but it is not the primary treatment for T1 NOMO laryngeal cancer.

**Clinical Pearl / High-Yield Fact**
For early-stage laryngeal cancer, the goal is to achieve a balance between oncological efficacy and preserving laryngeal function. Treatment choices should be individualized based on tumor characteristics, patient preferences, and functional status.

**Correct Answer: A. Endoscopic laser surgery.**